Back to results
US 2025/0378908 A1Published application
Identifying somatic pseudogenes as a proxy for restrotransposition activity detection
AssigneeGuardant Health, Inc.
InventorsVitaly BALAN, Aaron Isaac HARDIN, James HART, Sofia MEDINA RUIZ
Life of this patent
Estimating the term…
Abstract
Described herein is a method for detecting pseudogenes, including processed pseudogenes, further including detection for measuring retrotrasposon element activity. Such measurements are useful in screening and detecting cancer in subjects, including predicting the likelihood or cancer, recurrence, treatment responsiveness and selection.
Claims25
A method comprising:
- determining a plurality of sequence reads of a target region of a chromosome of a subject, wherein the target region of the chromosome comprises one or more loci;
- aligning the plurality of sequence reads to a reference genome;
- subtracting aligned pairs from the plurality of sequence reads to generate a plurality of candidate sequence reads;
- aligning the plurality of candidates sequences reads to a plurality of known allele sequences;
- determining, based on the alignment, for each known allele sequence of the plurality of known allele sequences, a number of sequence reads that aligned to each known allele sequence;
- extracting unaligned candidate sequence reads;
- mapping unaligned candidate sequence reads to the reference genome;
- and
- determining, based on the unaligned candidate sequence reads that mapped to the reference genome, one or more integration sites present at the one or more loci.
6 more elements
Dependencies are inferred from the claim text.